Press Release 2010

Press Release 2010

Sabinsa Corporation has a lot to talk about at SupplySide West this year. The company will introduce two new products: SabiLize™- Alpha and SabiLize- Beta. The company will be presenting a Vendor Works presentation on their proprietary Boswellin® PS. Given growing emphasis on products for intestinal health, Sabinsa will feature LactoWise and LactoSpore in their booth (#22027) throughout the show.

Sabinsa Corporation’s R&D group has developed two new patent pending ingredient compositions with proven preservative efficacy: SabiLize- Alpha and SabiLize-Beta. These proprietary blends of natural antimicrobial actives will help meet the all-too-common challenge of finding an effective natural preservative for use in cosmetics and personal care products. SabiLize-Alpha and SabiLize-Beta are blends of natural active fractions of various essential oils and phytoextracts. They do not irritate the skin. Both products are supported with safety and efficacy data. In laboratory studies, the preservative efficacy of these compositions was found to be superior to the conventionally used parabens.

Both SabiLize™- Alpha and SabiLize™- Beta at 0.5% in cream were found to be significantly effective against gram positive bacteria Staphylococcus aureus, Pseudomonas aeruginosa and Escherichia coli, as well as Candida albicans and Aspergillus niger. In laymen’s terms, these natural ingredients effectively keep commonly problematic bacteria from growing. Additionally, the active ingredients function as antioxidants and prevent the oxidation of oils and fats in cosmetic and personal care formulations.

Sabinsa’s presentation on Boswellin® PS will take place on Wednesday October 20, 2010, 4:00-4:50 pm in Galileo Rm. 901, Venetian Hotel, Las Vegas, NV. The gum resin of Boswellia serrata (N.O. Burseraceae) known as “Dhup”, Indian Frankincense, or Indian olibanum, is valued as a source of healthful phytonutrients. Such extracts are used as ingredients in dietary supplements and cosmetics, to support healthy aging. The most popular application in dietary supplements is in joint health support products, to support normal joint functions and mobility. Boswellin® PS represents an improvement over existing conventional Boswellia serrata extracts, providing manufacturers with a more water soluble version with enhanced joint health support potential. Boswellin® PS offers a unique release profile for the active ingredients.In addition to boswellic acids, (the active principles for which Boswellia extracts are conventionally standardized), the PS version contains Polysal, a natural polysaccharide fraction from the gum resin of Boswellia serrata. The Polysal fraction is water soluble , and enhances the healthful role of boswellic acids in the extract.

American’s have finally begun to embrace products for gut health, which have been accepted in other countries for a very long time. Sabinsa has a number of products in this category, which makes sense when you know that digestive health has been a cornerstone of Ayurvedic medicine for thousands of years. Sabinsa’s LactoWise is a Synbiotic: a proprietary combination of beneficial human intestinal microorganisms and dietary fiber for promoting gastrointestinal health. It contains soluble Fenumannans from the dietary fibers FenuFibers®, as well as LactoSpore®, Sabinsa’s branded and self-affirmed GRAS probiotic.

    VISIT US

  • Sabinsa Europe GmbH
    Monzastrasse 4
    63225 Langen
    Germany

  • +49 6103 270 11 11
  • +49 6103 270 11 27
  • info@sabinsa.eu

CERTIFICATES

Certificate Logos Certificate Logos
Certificate Logos Certificate Logos

CONTACT US

Disclaimer

Please note that this website and information provided herein is not for final consumers of a finished food, beverage, dietary supplement product or cosmetic product, as the information contained herein does not refer to finished products for consumers.

The information provided on the website is intended only for producers of finished food, beverage, dietary supplement and cosmetic product.

The statements related to ingredients on the website, have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease.

The website and information herein are available in various countries across the world, and hence statements or product information including its classification may not be applicable in your country.

Information and statements provided on the website, shall not be construed as license to practice, or recommendations to infringe, any patents or other intellectual property rights of Sabinsa and others.

By browsing further, You understand the above terms.